These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36186184)

  • 1. Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation.
    Leowattana W; Leowattana T; Leowattana P
    World J Clin Cases; 2022 Sep; 10(27):9588-9601. PubMed ID: 36186184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling.
    Gharanei M; Shafaattalab S; Sangha S; Gunawan M; Laksman Z; Hove-Madsen L; Tibbits GF
    Methods; 2022 Jul; 203():364-377. PubMed ID: 34144175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping.
    Gunawan MG; Sangha SS; Shafaattalab S; Lin E; Heims-Waldron DA; Bezzerides VJ; Laksman Z; Tibbits GF
    Stem Cells Transl Med; 2021 Jan; 10(1):68-82. PubMed ID: 32927497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation.
    Ly OT; Brown GE; Han YD; Darbar D; Khetani SR
    Exp Biol Med (Maywood); 2021 Aug; 246(16):1816-1828. PubMed ID: 33899540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation.
    Brown GE; Han YD; Michell AR; Ly OT; Vanoye CG; Spanghero E; George AL; Darbar D; Khetani SR
    Sci Adv; 2024 Jan; 10(3):eadg1222. PubMed ID: 38241367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C.
    Wang J; Ye Q; Bai S; Chen P; Zhao Y; Ma X; Bai C; Liu Y; Xin M; Zeng C; Liu Q; Zhao C; Yao Y; Ma Y
    J Mol Cell Cardiol; 2021 Jun; 155():58-65. PubMed ID: 33636223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant ANP induces mitochondrial and ion channel remodeling in a human iPSC-derived atrial fibrillation model.
    Ly OT; Chen H; Brown GE; Hong L; Wang X; Han YD; Pavel MA; Sridhar A; Maienschein-Cline M; Chalazan B; Ong SG; Abdelhady K; Massad M; Rizkallah LE; Rehman J; Khetani SR; Darbar D
    JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35393944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hiPSC-derived cardiomyocytes as a model to study the role of small-conductance Ca
    Babini H; Jiménez-Sábado V; Stogova E; Arslanova A; Butt M; Dababneh S; Asghari P; Moore EDW; Claydon TW; Chiamvimonvat N; Hove-Madsen L; Tibbits GF
    Front Cell Dev Biol; 2024; 12():1298007. PubMed ID: 38304423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes.
    Ahmed RE; Anzai T; Chanthra N; Uosaki H
    Front Cell Dev Biol; 2020; 8():178. PubMed ID: 32266260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Ventricular and Atrial Cardiomyocyte Subtypes from Human-Induced Pluripotent Stem Cells.
    Nakanishi-Koakutsu M; Takaki T; Miki K; Yoshida Y
    Methods Mol Biol; 2021; 2320():135-149. PubMed ID: 34302655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geometrical Patterning and Constituent Cell Heterogeneity Facilitate Electrical Conduction Disturbances in a Human Induced Pluripotent Stem Cell-Based Platform: An
    Nakanishi H; Lee JK; Miwa K; Masuyama K; Yasutake H; Li J; Tomoyama S; Honda Y; Deguchi J; Tsujimoto S; Hidaka K; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Front Physiol; 2019; 10():818. PubMed ID: 31316396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrarapid Delayed Rectifier K
    Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
    Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PITX2 deficiency leads to atrial mitochondrial dysfunction.
    Reyat JS; Sommerfeld LC; O'Reilly M; Cardoso VR; Thiemann E; Khan AO; O'Shea C; Harder S; Müller C; Barlow J; Stapley RJ; Chua W; Kabir SN; Grech O; Hummel O; Hübner N; Kääb S; Mont L; Hatem SN; Winters J; Zeemering S; Morgan NV; Rayes J; Gehmlich K; Stoll M; Brand T; Schweizer M; Piasecki A; Schotten U; Gkoutos GV; Lorenz K; Cuello F; Kirchhof P; Fabritz L
    Cardiovasc Res; 2024 Aug; ():. PubMed ID: 39129206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.
    Soepriatna AH; Kim TY; Daley MC; Song E; Choi BR; Coulombe KLK
    Cell Mol Bioeng; 2021 Oct; 14(5):441-457. PubMed ID: 34777603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-146b-5p promotes atrial fibrosis in atrial fibrillation by repressing TIMP4.
    Ye Q; Liu Q; Ma X; Bai S; Chen P; Zhao Y; Bai C; Liu Y; Liu K; Xin M; Zeng C; Zhao C; Yao Y; Ma Y; Wang J
    J Cell Mol Med; 2021 Nov; 25(22):10543-10553. PubMed ID: 34643044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Subtype-Specific Modeling of K
    Marczenke M; Piccini I; Mengarelli I; Fell J; Röpke A; Seebohm G; Verkerk AO; Greber B
    Front Physiol; 2017; 8():469. PubMed ID: 28729840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells.
    James EC; Tomaskovic-Crook E; Crook JM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
    Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 is required for structural and metabolic maturation of human induced pluripotent stem cell-derived ardiomyocytes.
    Zhang X; Ye L; Xu H; Zhou Q; Tan B; Yi Q; Yan L; Xie M; Zhang Y; Tian J; Zhu J
    Stem Cell Res Ther; 2021 Mar; 12(1):208. PubMed ID: 33762018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.